Background: Mupirocin has used to treat staphylococcal skin infections as well as to eliminate nasal carriage of Staphylococcus aureus. Mupirocin resistant S. aureus strains are seen worldwide but there is no report from Iran. This study was performed to investigate the presence of mupirocin resistant strains in S. aureus isolated from patients in Tehran. Methods: Presence of mupA gene, responsible for mupirocin resistance, was determined by PCR method. Disk diffusion and E-test were also used for demonstrating mupirocin resistance. The susceptibility testing of S. aureus isolates were carried out by the disk diffusion method. Moreover, PCR method was used for detection of mecA gene, which conferring resistance to methicillin and other penicillinase resistant penicillins. Result: Among 94 isolates of S. aureus, six strains were resistant to mupirocin; 5 low-level and 1 high-level resistance. From these 6 strains, mupA gene was shown in 5 strains. All mupirocin resistant strains were methicillin resistant by mecA gene PCR and disk diffusion test. Disk diffusion test had shown all mupirocin resistant strains were resistant to penicillin G, ampicillin, oxacillin, ciprofloxacin, tetracycline, trimethoprim-sulfamethoxazole, cefoxitin, clindamycin and erythromycin but all strains were shown susceptibility to vancomycin. Conclusion: This study is the first report about mupirocin resistance in S. aureus strains isolated from patients in Tehran and calls further studies for determination the incidence of this resistance. Also, a combination of PCR and phenotypic methods was recommended for a reliable identification of mupirocin resistance in S. aureus strains.

